Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1963 1
1964 1
1971 1
1974 1
1986 1
1987 2
1988 3
1989 2
1990 2
1991 1
1992 1
1993 3
1994 3
1995 2
1996 1
1997 2
1998 6
1999 2
2000 1
2001 1
2002 1
2003 4
2004 3
2005 1
2006 2
2007 3
2008 3
2009 6
2010 4
2011 6
2012 8
2013 11
2014 9
2015 8
2016 8
2017 5
2018 11
2019 7
2020 7
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

139 results
Results by year
Filters applied: . Clear all
Page 1
IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease.
Belarif L, Danger R, Kermarrec L, Nerrière-Daguin V, Pengam S, Durand T, Mary C, Kerdreux E, Gauttier V, Kucik A, Thepenier V, Martin JC, Chang C, Rahman A, Guen NS, Braudeau C, Abidi A, David G, Malard F, Takoudju C, Martinet B, Gérard N, Neveu I, Neunlist M, Coron E, MacDonald TT, Desreumaux P, Mai HL, Le Bas-Bernardet S, Mosnier JF, Merad M, Josien R, Brouard S, Soulillou JP, Blancho G, Bourreille A, Naveilhan P, Vanhove B, Poirier N. Belarif L, et al. Among authors: mary c. J Clin Invest. 2019 Apr 2;129(5):1910-1925. doi: 10.1172/JCI121668. eCollection 2019 Apr 2. J Clin Invest. 2019. PMID: 30939120 Free PMC article.
Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.
Gauttier V, Pengam S, Durand J, Biteau K, Mary C, Morello A, Néel M, Porto G, Teppaz G, Thepenier V, Danger R, Vince N, Wilhelm E, Girault I, Abes R, Ruiz C, Trilleaud C, Ralph K, Trombetta ES, Garcia A, Vignard V, Martinet B, Glémain A, Bruneau S, Haspot F, Dehmani S, Duplouye P, Miyasaka M, Labarrière N, Laplaud D, Le Bas-Bernardet S, Blanquart C, Catros V, Gouraud PA, Archambeaud I, Aublé H, Metairie S, Mosnier JF, Costantini D, Blancho G, Conchon S, Vanhove B, Poirier N. Gauttier V, et al. Among authors: mary c. J Clin Invest. 2020 Nov 2;130(11):6109-6123. doi: 10.1172/JCI135528. J Clin Invest. 2020. PMID: 33074246 Free PMC article.
Correction.
Luke NB, Emily BL, Suzanne EJ, Madeline RS, Parag G, Mary C, Monika MS, Orlando MG. Luke NB, et al. Among authors: mary c. JACC Heart Fail. 2019 Jul;7(7):636. doi: 10.1016/j.jchf.2019.05.002. JACC Heart Fail. 2019. PMID: 31248577 Free PMC article. No abstract available.
In response.
Mary C, Foissac M, Million M, Parola P, Piarroux R. Mary C, et al. Emerg Infect Dis. 2013 Nov;19(11):1905. doi: 10.3201/eid1911.131176. Emerg Infect Dis. 2013. PMID: 24344369 Free PMC article. No abstract available.
[Craniolacunia].
MARY C. MARY C. Lattante. 1952 Oct;23(10):591-9. Lattante. 1952. PMID: 13036227 Undetermined Language. No abstract available.
Which strategy after first-line therapy in advanced colorectal cancer?
Andrea C, Fausto P, Francesca BK, Mary C, Mara G, Veronica L, Sandro B. Andrea C, et al. Among authors: mary c. World J Gastroenterol. 2014 Jul 21;20(27):8921-7. doi: 10.3748/wjg.v20.i27.8921. World J Gastroenterol. 2014. PMID: 25083064 Free PMC article. Review.
Cutaneous leishmaniasis treated with azithromycin in a child.
Minodier P, Zambelli L, Mary C, Faraut F, Garnier JM, Berbis P. Minodier P, et al. Among authors: mary c. Pediatr Infect Dis J. 2008 Jan;27(1):80-1. doi: 10.1097/INF.0b013e3181506683. Pediatr Infect Dis J. 2008. PMID: 18162948 Review.
139 results